George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 2 Regulatory News (MIG)

Share Price Information for Mobeus I&g 2 (MIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.00
Bid: 57.50
Ask: 60.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.217%)
Open: 59.00
High: 59.00
Low: 57.50
Prev. Close: 59.00
MIG Live PriceLast checked at -
Mobeus Income & Growth 2 VCT is an Investment Trust

To provide investors with a regular income stream, arising both from the income generated by companies selected for the portfolio and from realising any growth in capital, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement to 31 December 2019

2 Mar 2020 10:23

RNS Number : 6732E
Mobeus Income & Growth 2 VCT PLC
02 March 2020
 

 

Mobeus Income & Growth 2 VCT plc (the “Company”)

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2019

 

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 31 December 2019. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 31 December 2019

At 30 September 2019

 

Net assets attributable to shareholders

 

£44.47m

£43.41m

Shares in issue

48,143,782

48,312,254

Net asset value (NAV) per share

 

92.37p

89.85p

Cumulative dividends paid to date per share since inception

98.00p

98.00p

Total return per share since inception (NAV basis)

190.37p

187.85p

FUNDRAISING

 

On 25 October 2019, the Company launched an Offer for Subscription ("Offer") to raise, up to £15 million, with an over-allotment facility to raise up to a further £5 million. Following robust demand from investors, the Directors approved the use of the over-allotment facility on 20 December 2019. On 8 January 2020, based on applications received up to 20 December 2019, 11,892,778 new Ordinary shares were allotted, generating net funds of £10.69 million for the Company. The Offer became fully subscribed on 13 January 2020. Due to this strong investor demand, on 6 February 2020 the Company announced that the Offer size would be further increased to raise up to a further £2.1 million. This increase was satisfied from applications already received in respect of the Offers, as announced on 28 February 2020.

 

In accordance with the Prospectus, these applications totalling approximately £11 million will be allotted shares in the Company between 1-3 April 2020.

 

DIVIDENDS

On 26 February 2020, the Company declared the payment of a second interim dividend of 11.00 pence per share in respect of the year ending 31 March 2020, to Shareholders on the register on 6 March 2020. This will be paid on 27 March 2020 and will bring the total paid in respect of this year to 26.00 pence per share.

 

SHARE BUY-BACKS

 

On 10 December 2019, the Company bought back 168,472 of its Ordinary shares at a price of 85.16

pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

INVESTMENT ACTIVITY

 

New investments

On 1 November 2019, the Company made a new investment of £0.94 million into Data Discovery Solutions Limited (trading as Active Navigation), a provider of enterprise-level file analysis software.

 

On 29 November 2019, the Company made a new investment of £0.54 million into IPV Limited, a developer of media asset management software.

 

On 13 December 2019, the Company made a new investment of £0.45 million into Bleach London Holdings Limited, an established and trusted brand in the hair colourants market.

 

Divestments

On 12 December 2019, the Company sold its investment in Redline Worldwide Limited, generating cash proceeds of £0.87 million. The realisation contributed, to date, to a return over the life of the investment of 1.6 times original cost. Deferred consideration of up to £0.16 million may be received over the next 30 months.

 

Divestments after the quarter end

On 7 February 2020, the Company's investment in Pattern Analytics Limited (trading as Biosite) was sold for proceeds of £1.53 million. Over the three years that this investment was held, these proceeds contributed to a multiple on cost of 1.5 times the original cost of investment. This realisation has had no material impact on the NAV per share as reported above.

 

On 13 February 2020, the Company sold its investment in Turner Topco Limited (trading as Auction Technology Group), generating cash proceeds of £4.55 million which, combined with returns received prior to a secondary buyout in June 2014, contributed to a multiple on original cost of 4.5 times over the 11 and a half years the investment was held. In isolation, the impact of this sale on the Company's NAV per share referred to above, would be an increase of 3.22p.

 

The Company emphasises that this figure is in isolation from any other changes in the Company's balance sheet, including other valuation movements in the Company's investment portfolio, that may affect the NAV per share during the current quarter.

 

Investments after the quarter end

On 28 February 2020, the Company made a new investment of £1.45 million into Bella & Duke Limited, a provider of premium frozen raw dog food to pet owners in the UK.

 

 

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

Please note that all of the information above is unaudited.

 

 

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBLLFBBXLFBBV
Date   Source Headline
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 202410:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
21st Feb 20247:00 amRNSInterim Management Statement
20th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:42 amRNSVoting Rights and Capital
23rd Jan 202412:45 pmRNSDirector Declaration - Non-Executive Appointment
22nd Jan 20242:00 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSINTERIM RESULTS TO 30 SEPTEMBER 2023
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
13th Sep 202312:15 pmRNSResult of AGM
13th Sep 202311:46 amRNSDividend Declaration - Replacement
13th Sep 202310:00 amRNSDividend Declaration
12th Sep 202310:30 amRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
19th Jul 20233:00 pmRNSTransaction in Own Shares
13th Jul 20237:00 amRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTotal Voting Rights
2nd May 202310:00 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202310:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
7th Mar 20237:30 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:32 pmRNSDividend Declaration
7th Feb 20235:00 pmRNSInterim Management Statement
6th Feb 20235:25 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:07 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:35 pmRNSTransaction in Own Shares
15th Dec 20229:36 amRNSINTERIM RESULTS TO 30 SEPTEMBER 2022
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
16th Nov 20225:52 pmRNSIssue of Equity and Total Voting Rights
8th Nov 20225:42 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
4th Nov 20229:50 amRNSDirectorate Change
3rd Nov 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.